• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴雷特肿瘤内镜切除术的组织病理学评估存在显著差异,这表明需要达成共识报告:改进建议。

Significant variation in histopathological assessment of endoscopic resections for Barrett's neoplasia suggests need for consensus reporting: propositions for improvement.

作者信息

van der Wel M J, Klaver E, Pouw R E, Brosens L A A, Biermann K, Doukas M, Huysentruyt C, Karrenbeld A, Ten Kate F J W, Kats-Ugurlu G, van der Laan J, van Lijnschoten I, Moll F C P, Offerhaus G J A, Ooms A H A G, Seldenrijk C A, Visser M, Tijssen J G, Meijer S L, Bergman J J G H M

机构信息

Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Dis Esophagus. 2021 Dec 24;34(12). doi: 10.1093/dote/doab034.

DOI:10.1093/dote/doab034
PMID:34100554
Abstract

Endoscopic resection (ER) is an important diagnostic step in management of patients with early Barrett's esophagus (BE) neoplasia. Based on ER specimens, an accurate histological diagnosis can be made, which guides further treatment. Based on depth of tumor invasion, differentiation grade, lymphovascular invasion, and margin status, the risk of lymph node metastases and local recurrence is judged to be low enough to justify endoscopic management, or high enough to warrant invasive surgical esophagectomy. Adequate assessment of these histological risk factors is therefore of the utmost importance. Aim of this study was to assess pathologist concordance on these histological features on ER specimens and evaluate causes of discrepancy. Of 62 challenging ER cases, one representative H&E slide and matching desmin and endothelial marker were digitalized and independently assessed by 13 dedicated GI pathologists from 8 Dutch BE expert centers, using an online assessment module. For each histological feature, concordance and discordance were calculated. Clinically relevant discordances were observed for all criteria. Grouping depth of invasion categories according to expanded endoscopic treatment criteria (T1a and T1sm1 vs. T1sm2/3), ≥1 pathologist was discrepant in 21% of cases, increasing to 45% when grouping diagnoses according to the traditional T1a versus T1b classification. For differentiation grade, lymphovascular invasion, and margin status, discordances were substantial with 27%, 42%, and 32% of cases having ≥1 discrepant pathologist, respectively. In conclusion, histological assessment of ER specimens of early BE cancer by dedicated GI pathologists shows significant discordances for all relevant histological features. We present propositions to improve definitions of diagnostic criteria.

摘要

内镜切除术(ER)是早期巴雷特食管(BE)肿瘤患者管理中的重要诊断步骤。基于ER标本,可以做出准确的组织学诊断,从而指导进一步治疗。根据肿瘤浸润深度、分化程度、淋巴管浸润和切缘状态,判断淋巴结转移和局部复发的风险足够低,足以证明内镜治疗的合理性,或者风险足够高,需要进行侵入性手术食管切除术。因此,对这些组织学危险因素进行充分评估至关重要。本研究的目的是评估病理学家对ER标本这些组织学特征的一致性,并评估差异的原因。在62例具有挑战性的ER病例中,一张代表性的苏木精-伊红(H&E)切片以及匹配的结蛋白和内皮标记物被数字化,并由来自8个荷兰BE专家中心的13名专门的胃肠病理学家使用在线评估模块进行独立评估。对于每个组织学特征,计算一致性和不一致性。所有标准均观察到临床相关的不一致性。根据扩大的内镜治疗标准(T1a和T1sm1与T1sm2/3)对浸润深度类别进行分组时,≥1名病理学家在21%的病例中存在差异,根据传统的T1a与T1b分类对诊断进行分组时,这一比例增加到45%。对于分化程度、淋巴管浸润和切缘状态,不一致性很大,分别有27%、42%和32%的病例有≥1名病理学家存在差异。总之,专门的胃肠病理学家对早期BE癌ER标本的组织学评估显示,所有相关组织学特征均存在显著不一致性。我们提出了改进诊断标准定义的建议。

相似文献

1
Significant variation in histopathological assessment of endoscopic resections for Barrett's neoplasia suggests need for consensus reporting: propositions for improvement.巴雷特肿瘤内镜切除术的组织病理学评估存在显著差异,这表明需要达成共识报告:改进建议。
Dis Esophagus. 2021 Dec 24;34(12). doi: 10.1093/dote/doab034.
2
Inter-Observer Variability in the Interpretation of Endoscopic Mucosal Resection Specimens of Esophageal Adenocarcinoma: Interpretation of ER specimens.食管腺癌内镜黏膜切除术标本解读中的观察者间差异:ER标本的解读
J Gastrointest Surg. 2016 Jan;20(1):140-4; discussion 144-5. doi: 10.1007/s11605-015-3009-7. Epub 2015 Oct 26.
3
Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low-risk tumours are not associated with lymph node metastases.内镜下切除 Barrett 腺癌:黏膜内和低危肿瘤与淋巴结转移无关。
United European Gastroenterol J. 2021 Apr;9(3):362-369. doi: 10.1177/2050640620958903. Epub 2021 Mar 15.
4
Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.早期 Barrett 腺癌和异型增生的内镜治疗:关注黏膜下癌。
Digestion. 2019;99(4):293-300. doi: 10.1159/000492217. Epub 2018 Sep 3.
5
Vertical tumor-positive resection margins and the risk of residual neoplasia after endoscopic resection of Barrett's neoplasia: a nationwide cohort with pathology reassessment.内镜切除 Barrett 肿瘤后,肿瘤阳性切缘与残留肿瘤风险的关系:全国性队列研究与病理学再评估。
Endoscopy. 2024 Aug;56(8):559-568. doi: 10.1055/a-2272-9794. Epub 2024 Feb 20.
6
AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.AGA 临床实践更新:内镜治疗伴异型增生和/或早期癌症的 Barrett 食管:专家综述。
Gastroenterology. 2020 Feb;158(3):760-769. doi: 10.1053/j.gastro.2019.09.051. Epub 2019 Nov 12.
7
The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review.巴雷特食管高级别异型增生或黏膜内癌患者的淋巴结转移风险:系统评价。
Am J Gastroenterol. 2012 Jun;107(6):850-62; quiz 863. doi: 10.1038/ajg.2012.78.
8
The modern management of Barrett's oesophagus and related neoplasia: role of pathology.巴雷特食管及相关肿瘤的现代管理:病理学的作用。
Histopathology. 2021 Jan;78(1):18-38. doi: 10.1111/his.14285.
9
Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study.内镜切除的食管黏膜下腺癌的淋巴结转移风险能否评估?一项多中心研究。
J Gastrointest Surg. 2016 Jan;20(1):6-12; discussion 12. doi: 10.1007/s11605-015-2950-9. Epub 2015 Sep 25.
10
Management of Nodular Neoplasia in Barrett's Esophagus: Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection.巴雷特食管结节状瘤变的管理:内镜下黏膜切除术和内镜黏膜下剥离术
Gastrointest Endosc Clin N Am. 2017 Jul;27(3):461-470. doi: 10.1016/j.giec.2017.02.004. Epub 2017 Mar 22.

引用本文的文献

1
Current status and perspectives of esophageal cancer: a comprehensive review.食管癌的现状与展望:全面综述
Cancer Commun (Lond). 2025 Mar;45(3):281-331. doi: 10.1002/cac2.12645. Epub 2024 Dec 26.
2
Prevalence and Risk Factors for Malignant Nodal Involvement in Early Esophago-Gastric Adenocarcinoma: Results From the Multicenter Retrospective Congress Study (endosCopic resectiON, esophaGectomy or Gastrectomy for Early Esophagogastric Cancers).早期食管胃腺癌恶性淋巴结受累的患病率及危险因素:多中心回顾性国会研究(早期食管胃癌的内镜切除、食管切除术或胃切除术)结果
Ann Surg. 2025 Mar 1;281(3):363-370. doi: 10.1097/SLA.0000000000006496. Epub 2024 Sep 2.
3
Can endoscopists judge a book by its cover when it comes to Barrett cancer?
在内镜检查医师判断巴雷特食管癌时,他们能以貌取“病”吗?
United European Gastroenterol J. 2024 Sep;12(7):827-828. doi: 10.1002/ueg2.12638. Epub 2024 Jul 15.
4
Vertical tumor-positive resection margins and the risk of residual neoplasia after endoscopic resection of Barrett's neoplasia: a nationwide cohort with pathology reassessment.内镜切除 Barrett 肿瘤后,肿瘤阳性切缘与残留肿瘤风险的关系:全国性队列研究与病理学再评估。
Endoscopy. 2024 Aug;56(8):559-568. doi: 10.1055/a-2272-9794. Epub 2024 Feb 20.
5
Today's Mistakes and Tomorrow's Wisdom… in the Management of T1b Barrett's Adenocarcinoma.T1b期巴雷特腺癌管理中的今日之误与明日之智
Visc Med. 2022 Jun;38(3):196-202. doi: 10.1159/000524285. Epub 2022 Apr 25.